These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 19758161

  • 1. B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease.
    Fabris M, De Vita S, Visentini D, Fabro C, Picierno A, Lerussi A, Villalta D, Alessio MG, Tampoia M, Tonutti E.
    Ann N Y Acad Sci; 2009 Sep; 1173():268-73. PubMed ID: 19758161
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J, Roubille C, Planelles L, Rocha C, Fernandez L, Lukas C, Hahne M, Combe B.
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [Abstract] [Full Text] [Related]

  • 3. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
    Jin R, Kaneko H, Suzuki H, Arai T, Teramoto T, Fukao T, Kondo N.
    Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
    [Abstract] [Full Text] [Related]

  • 4. BLyS and April serum levels in patients with autoimmune thyroid diseases.
    Fabris M, Grimaldi F, Villalta D, Picierno A, Fabro C, Bolzan M, De Vita S, Tonutti E.
    Autoimmun Rev; 2010 Jan; 9(3):165-9. PubMed ID: 19647102
    [Abstract] [Full Text] [Related]

  • 5. Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid.
    Watanabe R, Fujimoto M, Yazawa N, Nakashima H, Asashima N, Kuwano Y, Tada Y, Maruyama N, Okochi H, Tamaki K.
    J Dermatol Sci; 2007 Apr; 46(1):53-60. PubMed ID: 17250993
    [Abstract] [Full Text] [Related]

  • 6. Cytokine genotyping (TNF and IL-10) in patients with celiac disease and selective IgA deficiency.
    Cataldo F, Lio D, Marino V, Scola L, Crivello A, Mulè AM, Corazza GR, Groups of the SIGEP and "Club del Tenue".
    Am J Gastroenterol; 2003 Apr; 98(4):850-6. PubMed ID: 12738467
    [Abstract] [Full Text] [Related]

  • 7. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
    Matsushita T, Fujimoto M, Echigo T, Matsushita Y, Shimada Y, Hasegawa M, Takehara K, Sato S.
    Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
    [Abstract] [Full Text] [Related]

  • 8. B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection.
    Fabris M, Quartuccio L, Sacco S, De Marchi G, Pozzato G, Mazzaro C, Ferraccioli G, Migone TS, De Vita S.
    Rheumatology (Oxford); 2007 Jan; 46(1):37-43. PubMed ID: 16735452
    [Abstract] [Full Text] [Related]

  • 9. Serum BAFF and APRIL levels in patients with PBC.
    Migita K, Ilyassova B, Kovzel EF, Nersesov A, Abiru S, Maeda Y, Komori A, Ito M, Yano K, Yatsuhashi H, Shimoda S, Ishibashi H, Nakamura M.
    Clin Immunol; 2010 Feb; 134(2):217-25. PubMed ID: 19840904
    [Abstract] [Full Text] [Related]

  • 10. Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease.
    Fabris M, Visentini D, De Re V, Picierno A, Maieron R, Cannizzaro R, Villalta D, Curcio F, De Vita S, Tonutti E.
    Scand J Gastroenterol; 2007 Dec; 42(12):1434-9. PubMed ID: 17852877
    [Abstract] [Full Text] [Related]

  • 11. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis.
    Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, Migone TS, Hilbert DM, Stohl W.
    Arthritis Rheum; 2003 Apr; 48(4):982-92. PubMed ID: 12687540
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.
    Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, Slager S, Witzig TE, Shanafelt T, Call TG, Kay NE, Jelinek DF, Cerhan JR, Gross JA, Harder B, Dillon SR, Ansell SM.
    J Clin Oncol; 2006 Feb 20; 24(6):983-7. PubMed ID: 16432079
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency.
    Haimila K, Einarsdottir E, de Kauwe A, Koskinen LL, Pan-Hammarström Q, Kaartinen T, Kurppa K, Ziberna F, Not T, Vatta S, Ventura A, Korponay-Szabo IR, Adány R, Pocsai Z, Széles G, Dukes E, Kaukinen K, Mäki M, Koskinen S, Partanen J, Hammarström L, Saavalainen P.
    Genes Immun; 2009 Mar 20; 10(2):151-61. PubMed ID: 19020530
    [Abstract] [Full Text] [Related]

  • 17. Familial aggregation of IgAD and autoimmunity.
    Jorgensen GH, Thorsteinsdottir I, Gudmundsson S, Hammarstrom L, Ludviksson BR.
    Clin Immunol; 2009 May 20; 131(2):233-9. PubMed ID: 19167929
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.